Amneal Biosciences has received approval from the Food and Drug Administration (FDA) for Triamcinolone Acetonide Injectable Suspension 40mg/mL dosage strength, an AP-rated generic equivalent to Kenalog-40 Injection (Bristol-Myers Squibb).
Triamcinolone Acetonide Injectable Suspension is a synthetic glucocorticoid corticosteroid with anti-inflammatory action. It is indicated to treat corticosteroid-responsive disorders when oral therapy is not feasible.
The product will be available in 1mL single-dose vials as well as 5mL and 10mL multiple dose vials.
For more information visit Amneal.com.